What 23andMe’s Genetic Test Won’t Tell You About Risk of Alzheimer’s Disease
In April 2017, 23andMe received approval from the U.S. Food and Drug Administration (FDA) to sell a genetic health risk test directly to consumers. The resulting DNA test report contains interesting information on “wellness” traits, such as how quickly one will metabolize caffeine, predispositions to alcohol flush reaction, sleep movement, lactose intolerance, and more. The… Read More »